Compare Definium Therapeutics Inc. Common Shares (DFTX) vs SoundHound AI Inc (SOUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs SoundHound AI Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while SoundHound AI Inc trades at $5.58 (market cap $2.50B). The key difference: Definium Therapeutics Inc. Common Shares is the larger of the two by market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, SoundHound AI Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and SoundHound AI Inc for 23 Days on average.
| DFTX | SOUN | |
|---|---|---|
Market Cap | $4.71B | $2.50B |
Volume | 1,966,636 | 14,612,912 |
Sector | Health | Technology |
52-Week High | $48.45 | $21.40 |
52-Week Low | $10.68 | $5.52 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $3.67B | $2.30B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SoundHound AI (SOUN) trades at $5.63, down 1.57% on the day, with bearish technical signals from moving averages but bullish oscillators. The company shows strong revenue growth with 2025 revenue of $168.92M and projected 2026 revenue of $203M, though it remains unprofitable with a -67.45% net income margin. Recent developments include expansion in restaurant and banking sectors with new OASYS Edge technology for embedded voice AI.
While analyst consensus is strongly bullish with a $9.33 price target (75% buy ratings), significant risks include persistent losses, negative cash flow projections for 2026, and insider selling activity. The stock offers substantial upside potential if execution improves but carries high risk until profitability is achieved.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →
